What’s new in minimal residual disease (MRD) detection in myeloma?
Do Philadelphia chromosome-positive ALL patients need a stem cell transplant?
Novel issues in the combined modality treatment of lymphomas
The future of lymphoma treatment – combining new therapies with molecular diagnosis
Repurposed HIV and arthritis drugs in the treatment of leukaemia
Steven T. Rosen